Skip to main content
. 2017 May 11;14(6):2147–2157. doi: 10.1021/acs.molpharmaceut.7b00308

Figure 3.

Figure 3

Cetuximab-mediated regulation of EGFR downstream signaling. Cetuximab (CTX) promoted the activation of STK and phospholipases leading to PI3K-AKT and MAPK-ERK regulation of renal drug transporters. Data in panel B is expressed as mean values ± SEM of a minimum of two independent assays performed in triplicate.